Related Experiment Video
Updated: Oct 21, 2025

Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions
Published on: September 22, 2023
Transcriptomic Signatures of Airway Epithelium Infected With SARS-CoV-2: A Balance Between Anti-infection and Virus
Lingzhang Meng1, Houji Qin2, Jingjie Zhao3
1Center for Systemic Inflammation Research (CSIR), School of Preclinical Medicine, Youjiang Medical University for Nationalities, Baise, China.
Abstract:
COVID-19 pneumonia requires effective medical therapies. However, it is a challenge to find therapeutic drugs that not only inhibit viral replication, but also inhibit the accompanying cytokine storm and maintain an appropriate immune response. In this study, the effects of SARS-CoV-2 on gene expression in lung epithelial cells from patients with COVID-19 were systematically evaluated with bioinformatics analysis methods. Transcriptome expression specific to bystander (exposed but uninfected) and infected cells were found, and the vital pathways were identified by conducting differentially expressed gene analysis regarding the relationship between gene signatures of COVID-19 infection and disease severity. We found that a high viral load did not necessarily imply a low response of epithelial cells or a poor disease convalescence. The ability to distinguish the role of virus-correlated genes facilitates the development of potential new medicines and therapies for COVID-19 infection.
Insights
This study analyzed gene expression in lung cells affected by COVID-19 pneumonia. Identifying virus-correlated genes aids in developing new therapies for this respiratory illness.
Area of Science:
- * Molecular biology
- * Bioinformatics
- * Immunology
Background:
- * COVID-19 pneumonia necessitates therapies targeting viral replication, cytokine storms, and immune response.
- * Current therapeutic strategies face challenges in addressing these multifaceted aspects of the disease.
Purpose of the Study:
- * To systematically evaluate the effects of SARS-CoV-2 on gene expression in lung epithelial cells from COVID-19 patients.
- * To identify vital pathways by analyzing differentially expressed genes in relation to disease severity.
- * To distinguish the roles of virus-correlated genes for potential therapeutic development.
Main Methods:
- * Bioinformatics analysis of transcriptome expression in bystander and infected lung epithelial cells.
- * Differentially expressed gene analysis to correlate gene signatures with COVID-19 infection and disease severity.
Main Results:
- * Identified distinct transcriptome expression patterns in bystander and infected lung epithelial cells.
- * Found that high viral load does not always correlate with poor epithelial cell response or disease convalescence.
- * Identified key pathways influenced by SARS-CoV-2 infection.
Conclusions:
- * Understanding virus-correlated gene expression is crucial for COVID-19 treatment.
- * This research facilitates the development of novel medicines and therapies for COVID-19.
- * Gene expression analysis provides insights into host response and disease progression.

